Evidence map›Paper›PMID 27826299›Full record

ArticleFrontiers in immunology2016

Rajeev Kumar Pandey, Sanjana Mehrotra, Smriti Sharma, Ramachandra Subbaraya Gudde, Shyam Sundar, Chandrima Shaha

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 40 citations in OpenAlex.

  1. An inclusive assessment of apoptosis mechanisms inCurrent research in parasitology & vector-borne diseases · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. The role of CD4Frontiers in cellular and infection microbiology · 2024
    Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Modulation of Macrophage Redox and Apoptotic Processes toPathogens (Basel, Switzerland) · 2023
    Article
  11. Article
  12. Turkish journal of pharmaceutical sciences · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Tissue/Biofluid Specific Molecular Cartography ofFrontiers in cellular and infection microbiology · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Rajeev Kumar PandeyCell Death and Differentiation Research Laboratory, National Institute of Immunology , New Delhi , India.
Sanjana MehrotraDepartment of Human Genetics, Guru Nanak Dev University , Amritsar , India.
Smriti SharmaDepartment of Medicine, Institute of Medical Sciences, Infectious Disease Research Laboratory, Banaras Hindu University , Varanasi , India.
Ramachandra Subbaraya GuddeCentral Animal Facility, Indian Institute of Science , Bangalore , India.
Shyam SundarDepartment of Medicine, Institute of Medical Sciences, Infectious Disease Research Laboratory, Banaras Hindu University , Varanasi , India.
Chandrima ShahaCell Death and Differentiation Research Laboratory, National Institute of Immunology , New Delhi , India.
National Institute of Immunology · INBanaras Hindu University · INGuru Nanak Dev University · INIndian Institute of Science Bangalore · INInstitute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Members of the Bcl-2 family are major regulators of apoptosis in mammalian cells, and hence infection-induced perturbations in their expression could result into elimination of the parasites or creation of a niche favoring survival. In this investigation, we uncover a novel role of host Bcl-2 in sustaining

Indexed as

ABT-199Bcl-2IL-13Leishmania donovanimacrophagenitric oxide

Identifiers

PMID27826299
PMCPMC5078497
OpenAlexW2538524875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.